Abstract
We report the first case of Engyodontium album bioprosthetic valve endocarditis in a 44-year-old male with a history of juvenile rheumatoid arthritis. There is only one other report of Engyodontium album as a human pathogen. The present case supports the increased incidence of fungal endocarditis especially in patients receiving immunotherapy.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Adult
-
Antifungal Agents / therapeutic use
-
Arthritis, Juvenile / complications
-
Arthritis, Juvenile / microbiology
-
Ascomycota / classification
-
Ascomycota / drug effects
-
Ascomycota / genetics
-
Ascomycota / isolation & purification
-
Beauveria / classification
-
Beauveria / drug effects
-
Beauveria / genetics
-
Beauveria / isolation & purification*
-
DNA, Fungal / genetics
-
Endocarditis / drug therapy
-
Endocarditis / microbiology*
-
Heart Valve Prosthesis / microbiology
-
Humans
-
Male
-
Mitral Valve / microbiology*
-
Mitral Valve / surgery
-
Mycoses / drug therapy*
-
Prosthesis-Related Infections / microbiology*
-
Pyrimidines / therapeutic use
-
Reoperation
-
Sequence Analysis, DNA
-
Triazoles / therapeutic use
-
Voriconazole
Substances
-
Antifungal Agents
-
DNA, Fungal
-
Pyrimidines
-
Triazoles
-
Voriconazole